• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Competitive Fitness of Influenza B Viruses with Neuraminidase Inhibitor-Resistant Substitutions in a Co-infection Model of the Human Airway Epithelium

tetano

Editor, Senior Moderator
J Virol. 2015 Feb 11. pii: JVI.02473-14. [Epub ahead of print]
[h=1]Competitive Fitness of Influenza B Viruses with Neuraminidase Inhibitor-Resistant Substitutions in a Co-infection Model of the Human Airway Epithelium.[/h] Burnham AJ[SUP]1[/SUP], Armstrong J[SUP]1[/SUP], Lowen AC[SUP]2[/SUP], Webster RG[SUP]1[/SUP], Govorkova EA[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A and B viruses are regarded almost equally as human pathogens with significant disease burden. Neuraminidase (NA) inhibitors (NAIs) are the only class of drugs available to treat influenza A and B virus infections, so development of NAI-resistant viruses with superior fitness is a public health concern. Fitness of NAI-resistant influenza B viruses is not widely studied. Here we examined the replicative capacity and relative fitness in normal human bronchial epithelial (NHBE) cells of recombinant (rg) influenza B/Yamanashi/166/1998 viruses containing a single amino acid substitution in NA that is associated with NAI-resistance. Replication in NHBE cells of viruses with reduced inhibition by oseltamivir (rg-E119A, rg-D198E, rg-I222T, rg-H274Y, rg-N294S, and rg-R371K, N2 numbering) or zanamivir (rg-E119A and rg-R371K) failed to be inhibited by the presence of the respective NAI. In a fluorescence-based assay, detection of rg-E119A was easily masked by the presence of NAI-susceptible virus. We co-infected NHBE cells with NAI-susceptible and -resistant viruses and used next-generation deep-sequencing to reveal the order of relative fitness -compared to that of wild-type (WT) virus: rg-H274Y > rg-WT > rg-I222T > rg-N294S > rg-D198E > rg-E119A >> rg-R371K. Based on the lack of attenuated replication of rg-E119A in NHBE cells in the presence of oseltamivir or zanamivir, and the fitness advantage of rg-H274Y over rg-WT, we emphasize the importance of these substitutions in the NA glycoprotein. Human infections with influenza B viruses carrying E119A or H274Y substitutions could limit therapeutic options for those infected; emergence of such viruses should be closely monitored.
[h=4]IMPORTANCE:[/h] Influenza B viruses are important human respiratory pathogens contributing to a significant portion of seasonal influenza infections worldwide. The development of resistance to a single class of available antivirals, the neuraminidase (NA) inhibitors (NAIs), is a public health concern. Amino acid substitutions in the NA glycoprotein of influenza B virus can not only confer antiviral resistance but also alter viral fitness. Here we use normal human bronchial epithelial (NHBE) cells, a model of the human upper respiratory tract, to examine replicative capacities and fitness of NAI-resistant influenza B viruses. We show that virus with an E119A NA substitution can replicate efficiently in NHBE cells in the presence of oseltamivir or zanamivir and that virus with the H274Y NA substitution has a relative fitness greater than that of the wild-type NAI-susceptible virus. This study is the first to use NHBE cells to determine the fitness of NAI-resistant influenza B viruses.
Copyright ? 2015, American Society for Microbiology. All Rights Reserved.


PMID: 25673705 [PubMed - as supplied by publisher]
 
Back
Top Bottom